Citadel Advisors’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$152K Buy
20,900
+2,400
+13% +$21.7K ﹤0.01% 11666
2025
Q4
$178K Sell
18,500
-21,000
-53% -$217K ﹤0.01% 11134
2025
Q3
$482K Buy
39,500
+19,300
+96% +$203K ﹤0.01% 9229
2025
Q2
$161K Sell
20,200
-8,000
-28% -$56.2K ﹤0.01% 10892
2025
Q1
$205K Buy
28,200
+24,800
+729% +$180K ﹤0.01% 10405
2024
Q4
$23.4K Sell
3,400
-4,100
-55% -$28.2K ﹤0.01% 13071
2024
Q3
$55.3K Sell
7,500
-5,900
-44% -$55.1K ﹤0.01% 11796
2024
Q2
$141K Buy
13,400
+3,100
+30% +$39.3K ﹤0.01% 10431
2024
Q1
$142K Sell
10,300
-2,300
-18% -$35.9K ﹤0.01% 10836
2023
Q4
$245K Buy
12,600
+3,900
+45% +$72K ﹤0.01% 9563
2023
Q3
$185K Sell
8,700
-800
-8% -$20.8K ﹤0.01% 10048
2023
Q2
$315K Buy
9,500
+5,100
+116% +$188K ﹤0.01% 8939
2023
Q1
$173K Sell
4,400
-3,700
-46% -$154K ﹤0.01% 10416
2022
Q4
$341K Sell
8,100
-60,900
-88% -$2.34M ﹤0.01% 9031
2022
Q3
$2.3M Buy
69,000
+54,800
+386% +$2.28M ﹤0.01% 5321
2022
Q2
$615K Sell
14,200
-14,300
-50% -$656K ﹤0.01% 8180
2022
Q1
$1.36M Buy
28,500
+12,300
+76% +$610K ﹤0.01% 6942
2021
Q4
$822K Sell
16,200
-47,100
-74% -$2.09M ﹤0.01% 8423
2021
Q3
$2.56M Buy
63,300
+40,800
+181% +$2.06M ﹤0.01% 5751
2021
Q2
$1.27M Buy
22,500
+1,800
+9% +$102K ﹤0.01% 7709
2021
Q1
$1.09M Sell
20,700
-1,600
-7% -$87.2K ﹤0.01% 7890
2020
Q4
$1.22M Buy
22,300
+5,900
+36% +$310K ﹤0.01% 6381
2020
Q3
$821K Buy
16,400
+1,500
+10% +$71.1K ﹤0.01% 6386
2020
Q2
$570K Sell
14,900
-7,500
-33% -$241K ﹤0.01% 6844
2020
Q1
$489K Buy
22,400
+9,200
+70% +$277K ﹤0.01% 6495
2019
Q4
$541K Sell
13,200
-1,300
-9% -$53.1K ﹤0.01% 6694
2019
Q3
$617K Sell
14,500
-7,000
-33% -$294K ﹤0.01% 6401
2019
Q2
$1.06M Sell
21,500
-13,000
-38% -$661K ﹤0.01% 5607
2019
Q1
$1.65M Buy
34,500
+11,800
+52% +$715K ﹤0.01% 4770
2018
Q4
$1.39M Buy
22,700
+900
+4% +$60.7K ﹤0.01% 4755
2018
Q3
$1.8M Sell
21,800
-9,900
-31% -$787K ﹤0.01% 4586
2018
Q2
$2.48M Buy
31,700
+6,700
+27% +$519K ﹤0.01% 3766
2018
Q1
$1.84M Sell
25,000
-3,700
-13% -$263K ﹤0.01% 3855
2017
Q4
$1.96M Sell
28,700
-12,600
-31% -$815K ﹤0.01% 3670
2017
Q3
$2.54M Buy
41,300
+2,000
+5% +$123K ﹤0.01% 3124
2017
Q2
$2.47M Buy
39,300
+10,000
+34% +$570K ﹤0.01% 2893
2017
Q1
$1.63M Sell
29,300
-11,700
-29% -$602K ﹤0.01% 3315
2016
Q4
$1.96M Buy
41,000
+6,800
+20% +$381K ﹤0.01% 2974
2016
Q3
$2.21M Buy
34,200
+11,600
+51% +$652K ﹤0.01% 2846
2016
Q2
$1.04M Sell
22,600
-20,600
-48% -$830K ﹤0.01% 3499
2016
Q1
$1.65M Buy
43,200
+5,400
+14% +$179K ﹤0.01% 2864
2015
Q4
$1.43M Sell
37,800
-12,700
-25% -$468K ﹤0.01% 3149
2015
Q3
$2.08M Sell
50,500
-58,700
-54% -$2.52M ﹤0.01% 2886
2015
Q2
$5.15M Buy
109,200
+36,700
+51% +$1.99M ﹤0.01% 2040
2015
Q1
$4.37M Sell
72,500
-24,300
-25% -$1.24M ﹤0.01% 2170
2014
Q4
$4.23M Sell
96,800
-80,400
-45% -$3.55M ﹤0.01% 2132
2014
Q3
$7.98M Buy
177,200
+64,900
+58% +$3.45M 0.01% 1556
2014
Q2
$8.31M Sell
112,300
-45,600
-29% -$3.59M 0.01% 1411
2014
Q1
$13.1M Buy
157,900
+16,300
+12% +$1.43M 0.02% 1100
2013
Q4
$19.6M Buy
141,600
+46,800
+49% +$5.51M 0.03% 812
2013
Q3
$9.08M Buy
94,800
+38,200
+67% +$3.24M 0.01% 1157
2013
Q2
$3.46M Buy
+56,600
New +$3.14M 0.01% 1923

Other funds holding NUS

Citadel Advisors's NUS Position: Q1 2026 in Review

Citadel Advisors opened a new position in Nu Skin (NUS) in Q1 2026: 227,385 shares worth $1.66M. The stake represents ﹤0.01% of the portfolio and ranks #6509 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in NUS as recently as Q3 2025.

Citadel Advisors first reported a position in NUS in Q2 2013 and has held it in 49 quarters since. The position peaked at $31.5M in Q2 2019. 178 funds tracked by Wall St. Rank hold NUS as of Q1 2026.

  • Citadel Advisors held 227,385 shares of Nu Skin worth $1.66M as of Q1 2026.
  • Nu Skin was a new Citadel Advisors position in Q1 2026.
  • Nu Skin made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6509 holding.
  • Citadel Advisors first reported a position in Nu Skin in Q2 2013 and has held it in 49 quarters since.
  • Citadel Advisors's Nu Skin position peaked at $31.5M in Q2 2019.
  • 178 funds tracked by Wall St. Rank held Nu Skin as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.